IL31 and Alzheimer disease: Recently, a new network comprising IL-31+ M2 macrophages, basophils, periostin and TSLP has been described (13); nonetheless, the clinical relevance of these results are unknown due to lack of efficacy of TSLP blockade for AD treatment (68, 69).